We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBA icon
726
Pembina Pipeline
PBA
$28.4B
$685K 0.02%
17,999
RDS.B
727
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$683K 0.02%
8,740
-837
-9% -$63.5K
PWV icon
728
Invesco Large Cap Value ETF
PWV
$1.68B
$680K 0.02%
23,374
-3,725
-14% -$105K
ADM icon
729
Archer Daniels Midland
ADM
$38.2B
$677K 0.02%
15,603
-2,788
-15% -$115K
ICPT
730
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$677K 0.02%
+2,051
New +$692K
APOL
731
DELISTED
Apollo Education Group Inc Class A
APOL
$673K 0.02%
19,650
-49,000
-71% -$1.59M
PDP icon
732
Invesco Dorsey Wright Momentum ETF
PDP
$1.46B
$672K 0.02%
+18,034
New +$668K
PMFG
733
DELISTED
PMFG INC COM STK (DE)
PMFG
$671K 0.02%
112,350
+5,700
+5% +$40.6K
EWT icon
734
iShares MSCI Taiwan ETF
EWT
$9.86B
$669K 0.02%
23,239
-876
-4% -$24.4K
CMG icon
735
Chipotle Mexican Grill
CMG
$47.2B
$666K 0.02%
+58,650
New +$647K
CNP icon
736
CenterPoint Energy
CNP
$27.7B
$664K 0.02%
28,000
-234
-0.8% -$5.5K
BEAV
737
DELISTED
B/E Aerospace Inc
BEAV
$662K 0.02%
10,529
+2,987
+40% +$181K
MR
738
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$662K 0.02%
20,443
+263
+1% +$9.21K
OFS icon
739
OFS Capital
OFS
$45M
$661K 0.02%
52,864
-952
-2% -$12.1K
OGS icon
740
ONE Gas
OGS
$4.87B
$661K 0.02%
+18,418
New +$634K
HQH
741
abrdn Healthcare Investors
HQH
$1.25B
$658K 0.02%
24,741
+631
+3% +$17.5K
MUSA icon
742
Murphy USA
MUSA
$11.2B
$657K 0.02%
16,168
+2,318
+17% +$93.8K
PII icon
743
Polaris
PII
$3.82B
$654K 0.02%
4,680
-200
-4% -$27K
VRSK icon
744
Verisk Analytics
VRSK
$25.4B
$651K 0.02%
10,858
+4,891
+82% +$310K
PWB icon
745
Invesco Large Cap Growth ETF
PWB
$2.29B
$646K 0.02%
24,829
-4,364
-15% -$114K
XPO icon
746
XPO
XPO
$23.6B
$645K 0.02%
63,356
-311,192
-83% -$3.1M
CM icon
747
Canadian Imperial Bank of Commerce
CM
$108B
$644K 0.02%
15,240
-408
-3% -$16.4K
QIHU
748
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
$643K 0.02%
+6,450
New +$643K
YELP icon
749
Yelp
YELP
$1.45B
$641K 0.02%
8,340
+2,539
+44% +$215K
XLP icon
750
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$636K 0.02%
14,765
-100,757
-87% -$4.23M

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.